BREAKINGNY OCM pulls 54 lots from Keystone State Testing·DEVELOPINGOhio AG expands MSO cartel probe·JUST INIIPR files second eviction against PharmaCann·EXCLUSIVELeaked Slack messages show lab coordination·
Home/News/Health
HEALTH ALERT

Pesticide-Laced Weed: The Recalls, The Brands, The Risk to Your Lungs

Cannabis recalls in 2025-2026 revealed widespread pesticide contamination, including chlorfenapyr, spinosad, and myclobutanil, highlighting inadequate testing and health risks from inhalation.

By Cannabis Exposed Investigations Desk Friday, November 14, 2025 9 min read 0 views
Pesticide-Laced Weed: The Recalls, The Brands, The Risk to Your Lungs
Pesticide-Laced Weed: The Recalls, The Brands, The Risk to Your Lungs

The product passed lab testing. That's the line dispensaries reach for when a recall hits. The product passed lab testing, the recall is precautionary, the risk is minimal, please return any affected product to the point of purchase. Carry on.

The truth is uglier. Cannabis lab testing is performed by labs the brands themselves choose, in a regulatory environment where lab fraud has been documented in multiple states, against pesticide standards that were written for crops you eat — not for crops you set on fire and inhale through your lungs. When pesticide-contaminated cannabis "passes" testing, the testing is the failure. The contamination was always there.

Across 2025 and 2026, cannabis recalls hit nearly every legal state. Colorado alone issued eight pesticide-related recalls in just over two months. Maine expanded its vape cartridge recall multiple times. Arizona pulled distillates. New York pulled product associated with a single lab whose results were determined to be unreliable across 54 product lots.

This is what's actually been recalled. This is what's in it. And this is what it does to your lungs when you smoke it.

The Pesticide Showing Up Everywhere: Chlorfenapyr

If there's a single contaminant defining the 2025–2026 cannabis recall era, it's chlorfenapyr.

Chlorfenapyr is a pyrazole insecticide registered with the EPA for use on certain food crops. It is not approved for use on cannabis in any U.S. state. It is not approved for inhalation in any context. When combusted or vaporized, chlorfenapyr can convert into compounds with documented effects on the central nervous system.

Maine's Office of Cannabis Policy issued a recall in late 2025 covering vape cartridges produced by NorCO Outdoor Cannabis containing unsafe levels of chlorfenapyr. The recall warned that inhaling cannabis containing unsafe levels of chlorfenapyr can lead to high fever, sweating, nausea, vomiting, and altered mental status. The recall was subsequently expanded to additional strains.

Colorado's Marijuana Enforcement Division issued multiple chlorfenapyr-related recalls. A January 2026 recall hit nineteen dispensaries with batches from Rotation Farms that initially passed testing but exceeded limits on subsequent re-testing. A New Year's Eve recall covering Stash House CO products reached 295 stores across the state — including approximately 75 stores in Denver, 55 in Colorado Springs, and locations in Aurora, Fort Collins, Boulder, and other markets. Native Roots, The Green Solution, Star Buds, Green Dragon, and Igadi were among the chains that carried the affected products.

That's just two states in a few weeks. The pattern repeats nationally.

Other Banned Pesticides in the Recall History

Chlorfenapyr is not the only contaminant of concern. Recent recalls have involved a range of substances.

Spinosad. A neurotoxic insecticide derived from soil bacteria, registered with the EPA for various agricultural uses but not approved for combustible cannabis. Arizona dispensaries voluntarily recalled distillates from PRESSD Brands and edibles from Baked Bros in early 2026 due to potential spinosad contamination.

Myclobutanil. A fungicide notorious in the cannabis industry because it converts to hydrogen cyanide when heated. Has been at the center of recalls in Canada and multiple U.S. states. The Canadian class action against Canopy Growth and its subsidiary Mettrum centered on alleged use of unauthorized pesticides including myclobutanil.

Bifenthrin. A pyrethroid insecticide that has appeared in multiple state recalls. Linked to neurological symptoms when inhaled at elevated levels.

Eagle 20. Brand name for myclobutanil-based products. Has been documented in industry investigations as commonly used by illicit-market cultivators and occasionally found in regulated product where supply chains are compromised.

Imidacloprid. A neonicotinoid widely banned for outdoor agricultural use due to bee toxicity, occasionally detected in cannabis from outdoor and greenhouse cultivation operations.

The list of detected contaminants is not the full list of contaminants present. State testing requirements vary widely, and most state labs test for a limited panel of pesticides. A product that passes Colorado's mandatory panel may be carrying contaminants that Colorado doesn't test for at all.

Why Cannabis Pesticide Standards Are Inadequate

Most pesticide tolerance standards in agriculture are set by the EPA based on dietary exposure — how much of a substance you can safely consume in food over a lifetime. Cannabis exposure is fundamentally different. You don't eat cannabis (mostly). You combust it, vaporize it, or process it into concentrated forms. Each of those exposure pathways changes the toxicology dramatically.

When you set a pesticide-coated leaf on fire and inhale the smoke, you're not getting the same dose-response curve as when you eat that leaf. Combustion can break down the original pesticide into byproducts more toxic than the parent compound. Heat can volatilize substances that wouldn't be absorbed orally. The lung is not the gut — it has different absorption characteristics, no first-pass metabolism, and direct vascular access.

The federal government has not produced inhalation-specific tolerance standards for any pesticide-on-cannabis combination, because the federal government does not officially recognize cannabis as a legal product. State regulators have been left to invent standards, and the standards they invent are typically based on adapted versions of food-crop tolerances. The science is, at best, an educated guess.

Industry-funded toxicology research has begun to fill some gaps, but the work is fragmentary. The honest position is that we don't know exactly how much chlorfenapyr or spinosad or myclobutanil is safe in inhaled cannabis, because the studies haven't been done. State regulators set thresholds that look defensible. Brands hit those thresholds. Consumers inhale.

The Lab Testing Problem

The other half of the recall problem is that even within the inadequate standards we do have, the testing system that's supposed to enforce those standards has documented integrity failures.

In February 2026, the New York Office of Cannabis Management issued a precautionary recall after determining that Keystone State Testing New York had issued unreliable test results for several adult-use cannabis products. The audit identified 54 product lots where Aspergillus — a disease-causing mold — was reported falsely. One additional lot had cadmium, a heavy metal, reported incorrectly. The lab had been certifying products as safe that were not, in fact, safe.

This is not an isolated case. California, Florida, Nevada, and Oregon have all had documented cannabis testing lab problems — labs that systematically inflated potency results, suppressed pesticide detections, or issued certifications without performing the tests.

The economic incentive structure explains why. Testing labs compete for cannabis brand business. Brands prefer labs that issue favorable results. Labs that frequently fail products lose clients. Over time, this dynamic selects for labs willing to cut corners. Multiple states have caught labs in the act, but the underlying market structure that creates the incentive remains.

For consumers, this means the certificate of analysis (COA) on your cannabis product is a piece of evidence — not proof. It tells you what a lab said about a sample of the product. It does not tell you what's actually in the product on your dispensary shelf, especially if that lab turns out later to have been issuing fraudulent results.

How to Reduce Your Exposure

Eliminating pesticide exposure from cannabis is, at this stage of the industry, impossible. Reducing it is achievable.

Buy from cultivators who publish full-panel third-party testing. Some craft and medical-focused cultivators voluntarily test against panels broader than what state law requires, and use multiple labs to cross-verify. Their products typically carry a price premium. The premium is buying you data.

Avoid mass-market vape cartridges. Vape cartridges concentrate everything in the source material — pesticides, residual solvents, plasticizers from cheap hardware. Combustible flower at least burns off some compounds; vapes deliver concentrated doses of whatever's there. The bulk of the most alarming recalls in 2025–2026 have been on vape products.

Look for organic and Clean Green certified product. These are not federal standards, but they are voluntary third-party certifications that require pesticide-free cultivation practices and are audited annually. Not all such products live up to the labeling, but the certification at least establishes a baseline of intent.

Be skeptical of "indoor, premium" pricing as a quality signal. Indoor cultivation can be cleaner, but it can also be the highest-pesticide-use environment if growers are managing pest pressure with chemicals rather than integrated pest management. Outdoor and greenhouse cultivation often has lower pesticide loads when done by reputable operators.

Check state regulator recall databases regularly. Most states publish recall notices on cannabis regulator websites. If you've recently purchased product, check the regulator site. Affected batches are typically identifiable by batch number on the product label.

Take any unexpected respiratory or neurological symptoms seriously. Persistent cough after switching to a new cartridge, unusual headaches, gastrointestinal issues, or changes in mental status that correlate with cannabis use are worth investigating. State poison control hotlines accept cannabis-related calls. So do regulators, who can use consumer reports to trigger investigations.

What Brands Won't Tell You

The cannabis industry's response to the pesticide problem has been a mix of denial, deflection, and slow-motion accountability. The pattern is consistent across recalls.

The recall is announced as "precautionary" and "voluntary," even when state regulators have effectively forced the action.

The brand issues a statement emphasizing that no consumer harm has been reported and that the testing process worked.

The brand resumes operations within weeks, sometimes days, with new batches that ostensibly meet the standards the previous batches did not.

There is no public accounting of where the contaminated product came from in the supply chain. There is no public accounting of how the contamination occurred. There is no public accounting of what changed to prevent recurrence.

In some cases, the same brand will issue multiple recalls within months. Stash House CO and Rotation Farms — both featured in Colorado's late-2025 recall cascade — are not anomalies. They are examples of a structural problem that the industry has not solved.

The Larger Truth

Cannabis was supposed to be the cleaner alternative. To pharmaceuticals with their side-effect profiles. To alcohol with its known harms. To pre-legal cannabis with its unknown supply chains. The legal industry sold itself, and was sold to consumers, as the version where you could finally know what was in your weed.

What we have instead is an industry where pesticide-contaminated product reaches hundreds of dispensaries, where labs falsify test results across dozens of product lots, where the regulatory frameworks that exist are based on inadequate science, and where recall notices are issued as routine quarterly events rather than crisis-level public health communications.

This is fixable. Federal recognition of cannabis would unlock the EPA, the FDA, and the resources needed to develop inhalation-specific safety standards. State regulators could increase mandatory testing panels and require structural separations between brands and their chosen labs. Consumers could shift purchasing toward operators that demonstrate accountability rather than rewarding the cheapest cart.

Until those things happen, the responsibility for what enters your lungs falls on you. Read the recalls. Check the batch numbers. Ask the questions the dispensary doesn't volunteer. Trust the brands that earn it. Don't trust anyone who tells you the product passing testing means it's safe.

The product passing testing is the floor. It is not the ceiling.


Cannabis.exposed maintains a running tracker of all cannabis recalls in the United States. Bookmark it. Check it. Share it.

Internal links:

  • Every Cannabis Recall in 2025–2026: A Running List →
  • Fake Lab Results: How Cannabis Testing Labs Are Lying to Consumers →
  • What Is Chlorfenapyr and Why Is It Showing Up in Your Vape Cart →
Right of Reply

Named in this story?

We publish responses verbatim from anyone named here. Submit on the record or anonymously — legal reviews every reply, then it appears on this page next to the original reporting.

File a Response